Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


Copyright Notice

Pfizer SWOT

Pfizer—a ***** Analysis

Strengths

Pfizer is one of the world's leading research pharmaceutical companies and also one ***** the world's most profitable companies. It has a well-respected name known all over the world and commands some of the top research, advert*****ing, financial, and marketing talent. It produces two of the most well-known *****-brand drugs, Viagra and Lipitor in America today. Even ***** American Heart Association recommends the use of ***** such as Lipitor to reduce cholesterol when diet and exercise fail ***** reduce this common health problem. High cholesterol ***** a common health problem is only likely to increase with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied ***** Lipitor" which is dangerous for the company in the future as Lipitor's patent will expire ***** several years, ***** means it will face competition from cheaper, generic drugs (*****, 2007). Pfizer's reputation has ***** been tainted by its association with Celebrex, a p*****in medication that has been tied to increased risk of heart problems, in comparison to over-the-counter painkillers. The prominence of the Pfizer advertising campaign for this drug, followed by ***** rapid fall from grace undoubtedly damaged the company's trusted name.

Pfizer also manufactures Zol*****t, an antidepressant that was widely criticized for its over-prescription to teenager, and possibly causing ***** suicidal thoughts in this population. The company website now states that the drug is not advised for people under the age of 17. Antidepressants ***** 'lifestyle' drugs like Viagra have come under ********** media scrutiny and used as examples of the over-prescription of medication in the American healthcare system in general. Healthcare in America is grow*****g more and more expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay for drugs.

Now, Exubera, "the first ***** so far ***** commercially available inhaled-insulin diabetes treatment," ***** on the verge of turning in***** an "expensive failure" as Pfizer "has been dogged by questi*****s about ***** safety, cost *****d convenience" (Berenson, 2007).

*****

According to the ***** press release section of its website, discomfort associated ***** fibromyaglia, a common chronic pain condition, has ***** s*****n to be significantly reduced by a new drug developed by Pfizer called Lyrica, "according to study results presented today at the American Academy of Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has also developed a new AIDS drug called Maraviroc, which is likely to considerably improve and extend the life of AIDS patients who take the drug, according to researchers at the University of Pittsburg and Columbia University (Altman & Pollock, 2007).

Threats

Both Merck and Schering-Plough, ***** of Pfizer's greatest rivals, plan to combine forces ***** develop a medicine ***** rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in two ways, could hit the market when ***** patent expires in a few years" ("Merck and Schering-Plough Plan A*****her Cholesterol Drug,"

. . . . [END OF TERM PAPER PREVIEW]

Download complete paper (and others like it)    |    Order a brand new, customized paper

Other topics that might interest you:

© 2001–2016   |   Term Paper on Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Essays Examples